InMed Pharma: Cannabinoid Based on Pharmaceutical Products

© 2020 All Rights Reserved.

Cannabinoid based pharmaceutical product may help rare skin disease.

My name is Eric Adams. I’m the president and CEO of InMed Pharmaceuticals in Vancouver B.C.

About InMed BioPharmaceutical Company

InMed is a biopharmaceutical company that specializes in the research and development. It commercializes cannabinoid-based pharmaceutical products. Besides, we take this class of compounds known as cannabinoids. We plan these into disease-specific products to treat diseases with high medical needs. We differentiate ourselves from our competitors in three particular ways. First of all, we don’t grow any marijuana. Besides, we biosynthesize these compounds in a laboratory setting and use in our formulations. , we don’t use any THC in our products. Our goal is to treat the disease, not to have any psychoactive side effects that may affect the patient. This is important to cut the amount of drug that’s needed. It minimizes the amount that is circulating throughout the body. However, it is one of the most devastating diseases that most people never heard of. Epidermolysis Bullosa is most devastating diseases that most people never heard of. In addition to the improvement of symptoms, we believe there may be the potential for INM-750 to bring some degree of disease modification in patients with a certain type of EB called EB Simplex. InMed is an innovative pharmaceutical company that uses cutting edge technologies. Consequently, such technologies need to design products and deliver those to patients with the tuned is a biopharmaceutical company. Finally, it specializes in the research development and commercialization of cannabinoid-based pharmaceutical products most safety and efficacy. For more information on InMed Pharmaceuticals (IN:TSX,IMLFF:OTCQX) please fill out the form below.

Request Investor Info